KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$1.6 billion.

  • Bristol Myers Squibb's Other Gross PP&E Adjustments fell 1899.11% to -$1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 billion, marking a year-over-year decrease of 1899.11%. This contributed to the annual value of -$1.2 billion for FY2024, which is 1194.24% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Other Gross PP&E Adjustments of -$1.6 billion as of Q3 2025, which was down 1899.11% from -$1.3 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Other Gross PP&E Adjustments' 5-year high stood at -$840.0 million during Q2 2022, with a 5-year trough of -$1.6 billion in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's median Other Gross PP&E Adjustments value was -$1.2 billion (recorded in 2024), while the average stood at -$1.2 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Other Gross PP&E Adjustments skyrocketed by 1650.1% in 2022, and later crashed by 5481.31% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Other Gross PP&E Adjustments stood at -$919.0 million in 2021, then plummeted by 32.75% to -$1.2 billion in 2022, then decreased by 13.93% to -$1.4 billion in 2023, then increased by 11.94% to -$1.2 billion in 2024, then tumbled by 31.05% to -$1.6 billion in 2025.
  • Its Other Gross PP&E Adjustments stands at -$1.6 billion for Q3 2025, versus -$1.3 billion for Q2 2025 and -$1.2 billion for Q1 2025.